Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines

Breast Cancer Research

Volumn 11, Issue 6, 2009, Pages

  Nolens, Grégory ^a   Pignon, Jean Christophe ^a   Koopmansch, Benjamin ^a   Elmoualij, Benaïssa ^a   Zorzi, Willy ^a   De Pauw, Edwin ^a   Winkler, Rosita ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GLUCOKINASE; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; KU 70 PROTEIN; KU 80 PROTEIN; KU ANTIGEN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR AP 2ALPHA; TRANSCRIPTION FACTOR AP 2GAMMA; UNCLASSIFIED DRUG; CELL NUCLEUS ANTIGEN; DNA BINDING PROTEIN; MESSENGER RNA;

ARTICLE; BINDING SITE; BIOLOGICAL ACTIVITY; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN HCT116; CHROMATIN IMMUNOPRECIPITATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOWN REGULATION; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MASS SPECTROMETRY; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN PROTEIN INTERACTION; TWO DIMENSIONAL GEL ELECTROPHORESIS; WILD TYPE; BIOSYNTHESIS; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; TUMOR CELL LINE; UPREGULATION;

ANTIGENS, NUCLEAR; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; PROMOTER REGIONS, GENETIC; RECEPTOR, ERBB-2; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTOR AP-2; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

EID: 77954592554     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr2450     Document Type: Article

References (46)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007, 18:581-592. 10.1093/annonc/mdl498, 17287242.
2. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein LP, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 2001, 98:10869-10874. 58566, 11553815, 10.1073/pnas.191367098.
3. Sorlie T, Perou CM, Fan C, Geisler S, Aas T, Nobel A, Anker G, Akslen LA, Botstein D, Borresen-Dale AL, Lonning PE. Gene expression profiles do not consistently predict the clinical treatment response in locally advanced breast cancer. Mol Cancer Ther 2006, 5:2914-2918. 10.1158/1535-7163.MCT-06-0126, 17121939.
4. Ferretti G, Felici A, Papaldo P, Fabi A, Cognetti F. HER2/neu role in breast cancer: from a prognostic foe to a predictive friend. Curr Opin Obstet Gynecol 2007, 19:56-62. 10.1097/GCO.0b013e328012980a, 17218853.
5. Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer 2005, 5:341-354. 10.1038/nrc1609, 15864276.
6. Ross JS, Fletcher JA. The HER-2/neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy. Oncologist 1998, 3:237-252.
7. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987, 235:177-182. 10.1126/science.3798106, 3798106.
8. Pasleau F, Grooteclaes M, Gol-Winkler R. Expression of the c-erbB2 gene in the BT474 human mammary tumor cell line: measurement of c-erbB2 mRNA half-life. Oncogene 1993, 8:849-854.
9. Scott GK, Chang CH, Erny KM, Xu F, Fredericks WJ, Rauscher FJ, Thor AD, Benz CC. Ets regulation of the erbB2 promoter. Oncogene 2000, 19:6490-6502. 10.1038/sj.onc.1204041, 11175365.
10. Wu J, Lee C, Yokom D, Jiang H, Cheang MC, Yorida E, Turbin D, Berquin IM, Mertens PR, Iftner T, Gilks CB, Dunn SE. Disruption of the Y-box binding protein-1 results in suppression of the epidermal growth factor receptor and HER-2. Cancer Res 2006, 66:4872-4879. 10.1158/0008-5472.CAN-05-3561, 16651443.
11. Bosher JM, Williams T, Hurst HC. The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA 1995, 92:744-747. 42696, 7846046, 10.1073/pnas.92.3.744.
12. Grooteclaes M, Vernimmen D, Plaza S, Pasleau F, Hodzic D, Winkler-Gol R. A new cis element is involved in the HER2 gene overexpression in human breast cancer cells. Cancer Res 1999, 59:2527-2531.
13. Vernimmen D, Begon D, Salvador C, Gofflot S, Grooteclaes M, Winkler R. Identification of HTF (HER2 transcription factor) as an AP-2 (activator protein-2) transcription factor and contribution of the HTF binding site to ERBB2 gene overexpression. Biochem J 2003, 370:323-329. 1223148, 12418962, 10.1042/BJ20021238.
14. Delacroix L, Begon D, Chatel G, Jackers P, Winkler R. Distal ERBB2 promoter fragment displays specific transcriptional and nuclear binding activities in ERBB2 overexpressing breast cancer cells. DNA Cell Biol 2005, 24:582-594. 10.1089/dna.2005.24.582, 16153159.
15. Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene 1996, 13:1701-1707.
16. Pellikainen JM, Kosma VM. Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review. Int J Cancer 2007, 120:2061-2067. 10.1002/ijc.22648, 17330235.
17. Kannan P, Buettner R, Chiao PJ, Yim SO, Sarkiss M, Tainsky MA. N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev 1994, 8:1258-1269. 10.1101/gad.8.11.1258, 7926729.
18. Kannan P, Yu Y, Wankhade S, Tainsky MA. PolyADP-ribose polymerase is a coactivator for AP-2-mediated transcriptional activation. Nucleic Acids Res 1999, 27:866-874. 148259, 9889285, 10.1093/nar/27.3.866.
19. Braganca J, Swingler T, Marques FI, Jones T, Eloranta JJ, Hurst HC, Shioda T, Bhattacharya S. Human CREB-binding protein/p300-interacting transactivator with ED-rich tail (CITED) 4, a new member of the CITED family, functions as a co-activator for transcription factor AP-2. J Biol Chem 2002, 277:8559-8565. 10.1074/jbc.M110850200, 11744733.
20. Begon DY, Delacroix L, Vernimmen D, Jackers P, Winkler R. Yin Yang 1 cooperates with activator protein 2 to stimulate ERBB2 gene expression in mammary cancer cells. J Biol Chem 2005, 280:24428-24434. 10.1074/jbc.M503790200, 15870067.
21. Allouche A, Nolens G, Tancredi A, Delacroix L, Mardaga J, Fridman V, Winkler R, Boniver J, Delvenne P, Begon DY. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors. Breast Cancer Res 2008, 10:R9. 2374961, 18218085, 10.1186/bcr1851.
22. Li M, Wang Y, Hung MC, Kannan P. Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer. Int J Cancer 2006, 118:802-811. 10.1002/ijc.21426, 16108032.
23. Featherstone C, Jackson SP. Ku, a DNA repair protein with multiple cellular functions?. Mutat Res 1999, 434:3-15.
24. Gullo C, Au M, Feng G, Teoh G. The biology of Ku and its potential oncogenic role in cancer. Biochim Biophys Acta 2006, 1765:223-234.
25. Li G, Nelsen C, Hendrickson EA. Ku86 is essential in human somatic cells. Proc Natl Acad Sci USA 2002, 99:832-837. 117391, 11792868.
26. Matheos D, Novac O, Price GB, Zannis-Hadjopoulos M. Analysis of the DNA replication competence of the xrs-5 mutant cells defective in Ku86. J Cell Sci 2003, 116:111-124. 10.1242/jcs.00156, 12456721.
27. Zhang S, Schlott B, Gorlach M, Grosse F. DNA-dependent protein kinase (DNA-PK) phosphorylates nuclear DNA helicase II/RNA helicase A and hnRNP proteins in an RNA-dependent manner. Nucleic Acids Res 2004, 32:1-10. 373260, 14704337, 10.1093/nar/gkg933.
28. Buettner R, Kannan P, Imhof A, Bauer R, Yim SO, Glockshuber R, Van Dyke MW, Tainsky MA. An alternatively spliced mRNA from the AP-2 gene encodes a negative regulator of transcriptional activation by AP-2. Mol Cell Biol 1993, 13:4174-4185. 359967, 8321221.
29. Gaubatz S, Imhof A, Dosch R, Werner O, Mitchell P, Buettner R, Eilers M. Transcriptional activation by Myc is under negative control by the transcription factor AP-2. EMBO J 1995, 14:1508-1519. 398238, 7729426.
30. Ishiguro A, Ideta M, Mikoshiba K, Chen DJ, Aruga J. ZIC2-dependent transcriptional regulation is mediated by DNA-dependent protein kinase, poly(ADP-ribose) polymerase, and RNA helicase A. J Biol Chem 2007, 282:9983-9995. 10.1074/jbc.M610821200, 17251188.
31. Francis F, Gerkens P, Harmel N, Mazzucchelli G, De Pauw PE, Haubruge E. Proteomics in Myzus persicae: effect of aphid host plant switch. Insect Biochem Mol Biol 2006, 36:219-227. 10.1016/j.ibmb.2006.01.018, 16503483.
32. Chaplet M, Detry C, Deroanne C, Fisher LW, Castronovo V, Bellahcene A. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition. Biochem J 2004, 384:591-598. 1134145, 15324309, 10.1042/BJ20040380.
33. Dahl JA, Collas P. A rapid micro chromatin immunoprecipitation assay (microChIP). Nat Protoc 2008, 3:1032-1045. 10.1038/nprot.2008.68, 18536650.
34. Nguyen TN, Goodrich JA. Protein-protein interaction assays: eliminating false positive interactions. Nat Methods 2006, 3:135-139. 2730730, 16432524, 10.1038/nmeth0206-135.
35. Bertolini LR, Bertolini M, Anderson GB, Maga EA, Madden KR, Murray JD. Transient depletion of Ku70 and Xrcc4 by RNAi as a means to manipulate the non-homologous end-joining pathway. J Biotechnol 2007, 128:246-257. 10.1016/j.jbiotec.2006.10.003, 17097754.
36. Mayeur GL, Kung WJ, Martinez A, Izumiya C, Chen DJ, Kung HJ. Ku is a novel transcriptional recycling coactivator of the androgen receptor in prostate cancer cells. J Biol Chem 2005, 280:10827-10833. 10.1074/jbc.M413336200, 15640154.
37. Mo X, Dynan WS. Subnuclear localization of Ku protein: functional association with RNA polymerase II elongation sites. Mol Cell Biol 2002, 22:8088-8099. 134733, 12391174, 10.1128/MCB.22.22.8088-8099.2002.
38. Camara-Clayette V, Rahuel C, Bertrand O, Cartron JP. The E-box of the human glycophorin B promoter is involved in the erythroid-specific expression of the GPB gene. Biochem Biophys Res Commun 1999, 265:170-176. 10.1006/bbrc.1999.1634, 10548509.
39. Kim E, Li K, Lieu C, Tong S, Kawai S, Fukutomi T, Zhou Y, Wands J, Li J. Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis. J Hepatol 2008, 49:787-798. 2644636, 18809223, 10.1016/j.jhep.2008.06.029.
40. Kelavkar UP, Wang S, Badr KF. Ku autoantigen (DNA helicase) is required for interleukins-13/-4-induction of 15-lipoxygenase-1 gene expression in human epithelial cells. Genes Immun 2000, 1:237-250. 10.1038/sj.gene.6363665, 11196700.
41. Jiang D, Zhou Y, Moxley RA, Jarrett HW. Purification and identification of positive regulators binding to a novel element in the c-Jun promoter. Biochemistry 2008, 47:9318-9334. 10.1021/bi800285q, 18690718.
42. Wang H, Fang R, Cho JY, Libermann TA, Oettgen P. Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86. J Biol Chem 2004, 279:25241-25250. 10.1074/jbc.M401356200, 15075319.
43. Woodard RL, Lee KJ, Huang J, Dynan WS. Distinct roles for Ku protein in transcriptional reinitiation and DNA repair. J Biol Chem 2001, 276:15423-15433. 10.1074/jbc.M010752200, 11278739.
44. Idogawa M, Masutani M, Shitashige M, Honda K, Tokino T, Shinomura Y, Imai K, Hirohashi S, Yamada T. Ku70 and poly(ADP-ribose) polymerase-1 competitively regulate beta-catenin and T-cell factor-4-mediated gene transactivation: possible linkage of DNA damage recognition and Wnt signaling. Cancer Res 2007, 67:911-918. 10.1158/0008-5472.CAN-06-2360, 17283121.
45. Grote J, Konig S, Ackermann D, Sopalla C, Benedyk M, Los M, Kerkhoff C. Identification of poly(ADP-ribose)polymerase-1 and Ku70/Ku80 as transcriptional regulators of S100A9 gene expression. BMC Mol Biol 2006, 7:48. 1766928, 17187679, 10.1186/1471-2199-7-48.
46. Sucharov CC, Helmke SM, Langer SJ, Perryman MB, Bristow M, Leinwand L. The Ku protein complex interacts with YY1, is up-regulated in human heart failure, and represses alpha myosin heavy-chain gene expression. Mol Cell Biol 2004, 24:8705-8715. 516749, 15367688, 10.1128/MCB.24.19.8705-8715.2004.